Showing results (1-10 of 215) with videos related to
Sort By:
Pageof 22
Advances in Dermatology|January 1, 1997
Generalized atrophic benign epidermolysis bullosaT N Darling, J W Bauer, H Hintner, et al.The Journal of Clinical Investigation|May 20, 1999
Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutationT N Darling, C Yee, J W Bauer, et al.The Journal of Investigative Dermatology|February 11, 1998
Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosaT N Darling, C Yee, B Koh, et al.The Journal of Investigative Dermatology|February 11, 1998
A deletion mutation in COL17A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral alleleT N Darling, B B Koh, S J Bale, et al.The Journal of Investigative Dermatology|April 1, 1997
Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosaT N Darling, J A McGrath, C Yee, et al.Experimental Dermatology|March 13, 2003
Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseasesG Dallinger, M Puttaraju, L G Mitchell, et al.Lancet (London, England)|June 19, 2001
Anti-epiligrin cicatricial pemphigoid and relative risk for cancerC A Egan, Z Lazarova, T N Darling, et al.Journal of the American Academy of Dermatology|March 22, 2001
Large melanocytic nevi in hereditary epidermolysis bullosaJ W Bauer, H Schaeppi, C Kaserer, et al.Experimental Dermatology|August 1, 1995
Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosaG Pohla-Gubo, Z Lazarova, G J Giudice, et al.Archives of Dermatology|December 1, 1995
A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigensT N Darling, A A Cardenas, J S Beard, et al.Pageof 22